Edwards Commander Delivery System (9600LDS20; 9600LDS23; 9600LDS26; 9600LDS29; 9750CM20; 9750CM23; 9750CM26; 9750CM29)
Edwards Lifesciences, LLC · Decision date Jun 30, 2026
What did the FDA decide?
FDA records P140031/S205 as a supplement to PMA P140031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jun 30, 2026.
FDA approval order statement
implementation of an automated inspection spreadsheet during an incoming inspection
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140031/S205
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPT
- Decision code
- OK30
- Decision date
- Jun 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Aortic valve, prosthesis, percutaneously delivered.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPT
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140031. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140031 · Original PMA
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
P140031/S193 · Related supplement
Edwards Commander Delivery System: 9600LDS23, 9600LDS26, 9600LDS29 9750CM23, 9750CM26, 9750CM29
P140031/S194 · Related supplement
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
P140031/S195 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RES
P140031/S196 · Related supplement
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (sizes 20mm, 23mm, 26mm) 9750TFX; Edwards SAPIEN 3 Ultra RESILIA Transc
P140031/S197 · Related supplement
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve, Models 9755RSL20, 9755RSL23, 9755RSL26, and 9755RSL29
P140031/S189 · Related supplement
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
P140031/S199 · Related supplement
Edwards Commander Delivery System (9600LDS20, 9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26)
P140031/S200 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra
P140031/S198 · Related supplement
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
P140031/S201 · Related supplement
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve, SAPIEN 3 Ultra Transcatheter Heart Valve System
P140031/S203 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve System
P140031/S204 · Related supplement
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
P140031/S205 received
Application receipt date recorded by FDA.
P140031/S205 · FDA decision
30-Day Notice
P140031/S206 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RES
P140031/S192 · Related supplement
Edwards Crimper: 9600CR
P140031/S207 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX20, 9600TFX23, 9600TFX26, 9600TFX29); Edwards SAPIEN 3 Ultra Transcat
P140031/S208 · Related supplement
Edwards Certitude Delivery System (9600SDS20, 9600SDS23, 9600SDS26, 9600SDS29, 9630TA20, 9630TA23, 9630TA26, 9630TA29);
P140031/S209 · Related supplement
Edwards Crimper (9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26, 9750CM29)
P140031/S202 · Related supplement
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
P140031/S210 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX), Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (9750TFX)
Timeline entries are records held by MedtechLedger for P140031. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140031
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Jun 17, 2015 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 2, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 10, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 16, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Dec 17, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Dec 17, 2025 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Feb 3, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Feb 12, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Mar 11, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Apr 9, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Apr 16, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Apr 30, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jun 3, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 2, 2026 | FDA | |
Edwards Crimper: 9600CRP140031/S192 | Edwards Lifesciences, LLC | PMA supplement | Jul 17, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Jul 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code NPT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 7, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 29, 2026 | FDA | |
Trilogy Transcatheter Heart Valve SystemP250024/S005 | JenaValve Technology, Inc. | PMA supplement | Oct 13, 2026 | FDA |
Trilogy Transcatheter Heart Valve SystemP250024/S006 | JenaValve Technology, Inc. | PMA supplement | Oct 7, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P140031/S205
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


